Cargando…

Antimicrobial peptides against polymyxin-resistant Klebsiella pneumoniae: a patent review

The spread of polymyxin-resistant Klebsiella pneumoniae strains represents an emerging health challenge, limiting treatment options for the patients. Thus, the development of new antimicrobials is an urgent requirement. Antimicrobial peptides (AMPs) are a large class of compounds that are part of in...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Souza, Gleyce Hellen de Almeida, Rossato, Luana, de Oliveira, Alexandre Ribeiro, Simionatto, Simone
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889241/ https://www.ncbi.nlm.nih.gov/pubmed/36720739 http://dx.doi.org/10.1007/s11274-023-03530-6

Ejemplares similares

Genetic Diversity of Virulent Polymyxin-Resistant Klebsiella aerogenes Isolated from Intensive Care Units
por: da Silva, Kesia Esther, et al.
Publicado: (2022)

Multidrug-resistant gram-negative bacteria in patients with COVID-19: An epidemiological and clinical study
por: de Souza, Gleyce Hellen de Almeida, et al.
Publicado: (2023)

Overview of polymyxin resistance in Enterobacteriaceae
por: da Silva, Kesia Esther, et al.
Publicado: (2022)

Carbapenem-resistant Pseudomonas aeruginosa strains: a worrying health problem in intensive care units
por: de Souza, Gleyce Hellen de Almeida, et al.
Publicado: (2021)

How Did COVID-19 Impact the Antimicrobial Consumption and Bacterial Resistance Profiles in Brazil?
por: Massarine, Natália Cassago Marcos, et al.
Publicado: (2023)

In vitro and in vivo antibacterial activity assays of carvacrol: A candidate for development of innovative treatments against KPC-producing Klebsiella pneumoniae
por: de Souza, Gleyce Hellen de Almeida, et al.
Publicado: (2021)

New Technologies to Diagnose and Treat a Multidrug-Resistant Candida auris: A Patent Review
por: Rossato, Luana, et al.
Publicado: (2022)

Synergistic effects of Cinnamomum cassia L. essential oil in combination with polymyxin B against carbapenemase-producing Klebsiella pneumoniae and Serratia marcescens
por: Vasconcelos, Nathalie Gaebler, et al.
Publicado: (2020)

Resveratrol enhances the antimicrobial effect of polymyxin B on Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance
por: Liu, Li, et al.
Publicado: (2020)

Could the COVID-19 pandemic aggravate antimicrobial resistance?
por: Rossato, Luana, et al.
Publicado: (2020)

Polymyxins and Doripenem Combination Against KPC-Producing Klebsiella pneumoniae
por: Lee, Grace C., et al.
Publicado: (2013)

Antibacterial activity of Cinnamomum cassia L. essential oil in a carbapenem- and polymyxin-resistant Klebsiella aerogenes strain
por: Vasconcelos, Nathalie Gaebler, et al.
Publicado: (2020)

Difficulty in detecting low levels of polymyxin resistance in clinical Klebsiella pneumoniae isolates: evaluation of Rapid Polymyxin NP test, Colispot Test and SuperPolymyxin medium
por: Conceição-Neto, O.C., et al.
Publicado: (2020)

Non-clonal occurrence of pmrB mutations associated with polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae in Brazil
por: Rodrigues, Ana Claudia Souza, et al.
Publicado: (2019)

Molecular Analysis of Polymyxin Resistance among Carbapenemase-Producing Klebsiella pneumoniae in Colombia
por: De La Cadena, Elsa, et al.
Publicado: (2021)

Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae, São Paulo, Brazil
por: Bartolleti, Flávia, et al.
Publicado: (2016)

Outbreak report of polymyxin-carbapenem-resistant Klebsiella pneumoniae causing untreatable infections evidenced by synergy tests and bacterial genomes
por: Gomes, Marisa Zenaide Ribeiro, et al.
Publicado: (2023)

Polymyxin B and fusidic acid, a novel potent synergistic combination against Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance
por: Chen, Shuying, et al.
Publicado: (2023)

Disulfiram Enhances the Activity of Polymyxin B Against Klebsiella pneumoniae by Inhibiting Lipid A Modification
por: Huang, Wei, et al.
Publicado: (2022)

The Capsule Increases Susceptibility to Last-Resort Polymyxins, but Not to Other Antibiotics, in Klebsiella pneumoniae
por: D’Angelo, Francesca, et al.
Publicado: (2023)

Efficacy of tigecycline, polymyxin, gentamicin, meropenem and associations in experimental Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae non-lethal sepsis
por: Toledo, Paula Virginia Michelon, et al.
Publicado: (2014)

Pharmacokinetic and pharmacodynamic properties of polymyxin B in Escherichia coli and Klebsiella pneumoniae murine infection models
por: van der Meijden, Aart, et al.
Publicado: (2023)

2451. Synergistic Activity of Ceftazidime–Avibactam in Combination With Polymyxin B Against Carbapenem-Resistant Klebsiella pneumoniae
por: Borjan, Jovan, et al.
Publicado: (2018)

Multifactorial chromosomal variants regulate polymyxin resistance in extensively drug-resistant Klebsiella pneumoniae
por: Pitt, Miranda E., et al.
Publicado: (2018)

CrrB Positively Regulates High-Level Polymyxin Resistance and Virulence in Klebsiella pneumoniae
por: McConville, Thomas H., et al.
Publicado: (2020)

Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae
por: Tian, Yuan, et al.
Publicado: (2021)

Low performance of Policimbac® broth microdilution in determining polymyxin B MIC for Klebsiella pneumoniae
por: Rocha, Natália Conceição, et al.
Publicado: (2023)

Defining principles that influence antimicrobial peptide activity against capsulated Klebsiella pneumoniae
por: Fleeman, Renee M., et al.
Publicado: (2020)

In Vitro and In Vivo Synergism of Fosfomycin in Combination with Meropenem or Polymyxin B against KPC-2-Producing Klebsiella pneumoniae Clinical Isolates
por: Ribeiro, Aghata Cardoso da Silva, et al.
Publicado: (2023)

Extreme Antimicrobial Peptide and Polymyxin B Resistance in the Genus Burkholderia
por: Loutet, Slade A., et al.
Publicado: (2011)

Extreme Antimicrobial Peptide and Polymyxin B Resistance in the Genus Burkholderia
por: Loutet, Slade A., et al.
Publicado: (2011)

Antimicrobial Peptides for Gram-Negative Sepsis: A Case for the Polymyxins
por: David, Sunil A.
Publicado: (2012)

Ceftazidime/avibactam Improves the Antibacterial Efficacy of Polymyxin B Against Polymyxin B Heteroresistant KPC-2-Producing Klebsiella pneumoniae and Hinders Emergence of Resistant Subpopulation in vitro
por: Ma, Xingyan, et al.
Publicado: (2019)

Predicting Phenotypic Polymyxin Resistance in Klebsiella pneumoniae through Machine Learning Analysis of Genomic Data
por: Macesic, Nenad, et al.
Publicado: (2020)

Emergence of polymyxin B-heteroresistant hypervirulent Klebsiella pneumoniae from an individual in the community with asymptomatic bacteriuria
por: Li, Jun, et al.
Publicado: (2022)

Early use of polymyxin B reduces the mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection
por: Liang, Qiqiang, et al.
Publicado: (2019)

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae
por: Yu, Zhenwei, et al.
Publicado: (2022)

The Efficacy and Influencing Factors of Polymyxin B in High-Level Carbapenem-Resistant Klebsiella pneumoniae Infections
por: Jia, Xuedong, et al.
Publicado: (2023)

Pipeline validation for the identification of antimicrobial-resistant genes in carbapenem-resistant Klebsiella pneumoniae
por: Vieira, Andressa de Almeida, et al.
Publicado: (2023)

Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae
por: Diep, John K., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jg92ofr8ui0oofgh96gko7sbd7